1. Home
  2. CRMD vs UWMC Comparison

CRMD vs UWMC Comparison

Compare CRMD & UWMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • UWMC
  • Stock Information
  • Founded
  • CRMD 2006
  • UWMC 1986
  • Country
  • CRMD United States
  • UWMC United States
  • Employees
  • CRMD N/A
  • UWMC N/A
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • UWMC Finance: Consumer Services
  • Sector
  • CRMD Health Care
  • UWMC Finance
  • Exchange
  • CRMD Nasdaq
  • UWMC Nasdaq
  • Market Cap
  • CRMD 901.8M
  • UWMC 876.2M
  • IPO Year
  • CRMD 2010
  • UWMC N/A
  • Fundamental
  • Price
  • CRMD $13.69
  • UWMC $5.82
  • Analyst Decision
  • CRMD Strong Buy
  • UWMC Hold
  • Analyst Count
  • CRMD 7
  • UWMC 7
  • Target Price
  • CRMD $16.83
  • UWMC $5.54
  • AVG Volume (30 Days)
  • CRMD 3.4M
  • UWMC 10.4M
  • Earning Date
  • CRMD 08-07-2025
  • UWMC 08-07-2025
  • Dividend Yield
  • CRMD N/A
  • UWMC 7.43%
  • EPS Growth
  • CRMD N/A
  • UWMC 112.84
  • EPS
  • CRMD 0.79
  • UWMC 0.07
  • Revenue
  • CRMD $121,484,498.00
  • UWMC $2,622,828,000.00
  • Revenue This Year
  • CRMD $404.81
  • UWMC $16.65
  • Revenue Next Year
  • CRMD $56.11
  • UWMC $16.18
  • P/E Ratio
  • CRMD $17.30
  • UWMC $87.80
  • Revenue Growth
  • CRMD 14970.29
  • UWMC 13.45
  • 52 Week Low
  • CRMD $4.87
  • UWMC $3.80
  • 52 Week High
  • CRMD $17.43
  • UWMC $9.74
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 65.34
  • UWMC 72.08
  • Support Level
  • CRMD $12.80
  • UWMC $5.27
  • Resistance Level
  • CRMD $13.56
  • UWMC $5.68
  • Average True Range (ATR)
  • CRMD 0.86
  • UWMC 0.30
  • MACD
  • CRMD 0.27
  • UWMC 0.09
  • Stochastic Oscillator
  • CRMD 84.47
  • UWMC 95.56

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About UWMC UWM Holdings Corporation

UWM Holdings Corp engages in the origination, sale, and servicing of residential mortgage loans in the wholesale channel. The company provides independent mortgage advisors across the states and the district of Columbia.

Share on Social Networks: